Determination of carisoprodol and meprobamate in oral fluid

Journal of Analytical Toxicology

Volumn 36, Issue 3, 2012, Pages 217-220

  Coulter, Cynthia ^a   Garnier, Margaux ^a   Tuyay, James ^a   Orbita, Jonathan ^a   Moore, Christine ^a  

^a Immunalysis Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARISOPRODOL; MEPROBAMATE; CENTRAL MUSCLE RELAXANT;

ACCURACY; ARTICLE; DRUG SALIVA LEVEL; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LABORATORY DEVICE; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY COLUMN; MASS SPECTROMETRY; POSITIVE ION ELECTROSPRAY; QUANTISAL DEVICE; SOLID PHASE EXTRACTION; CALIBRATION; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REPRODUCIBILITY; SALIVA; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

CALIBRATION; CARISOPRODOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MEPROBAMATE; MUSCLE RELAXANTS, CENTRAL; REPRODUCIBILITY OF RESULTS; SALIVA; SOLID PHASE EXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84863591991     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks009     Document Type: Article

References (12)

1. Farrell, L.J., Kerrigan, S., Logan, B.K. (2007) Recommendations for toxicological investigation of drug impaired driving. Journal of Forensic Science, 52, 1214-1218.
2. Reeves, R.R., Burke, R.S. (2010) Carisoprodol: Abuse potential and withdrawal syndrome. Current Drug Abuse Reviews, 3, 33-38.
3. Reeves, R.R., Ladner, M.E. (2008) Carisoprodol withdrawal syndrome misdiagnosed as a psychotic disorder. Annals of Clinical Psychiatry, 20, 173-174.
4. Forrester, M.B. (2006) Carisoprodol abuse in Texas 1998-2003. Journal of Medical Toxicology, 2, 8-13.
5. Reeves, R.R., Henderson, R.H., Ladner, M.E. (2007) Carisoprodol abuse in Mississippi. Journal of the Missouri State Medical Association, 48, 363-365.
6. Fass, J.A. (2010) Carisoprodol legal status and patterns of abuse. Annals of Pharmacotherapy, 44, 1962-1967.
7. Øiestad, E.L., Johansen, U., Christophersen, A.S. (2007) Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clinical Chemistry, 53, 300-399.
8. Gjerde, H., Mordal, J., Christophersen, A.S., Bramness, J.G., Mørland, J. (2010) Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device. Journal of Analytical Toxicology, 34, 204-209.
9. Matuszewski, B.K., Constanzer, M.L., Chavez-Eng, C.M. (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry, 75, 3019-3030.
10. Roth, B.A., Vinson, D.R., Kim, S. (1998) Carisoprodol-induced myoclonic encephalopathy. Journal of Toxicology-Clinical Toxicology, 36, 609-612.
11. Backer, R.C., Zumwalt, R., McFeeley, P., Veasey, S., Wohlenberg, N. (1990) Carisoprodol concentrations from different anatomical sites: three overdose cases. Journal of Analytical Toxicology, 14, 332-334.
12. Logan, B.K., Case, G.A., Gordon, A.M. (2000) Carisoprodol, meprobamate and driving impairment. Journal of Forensic Science, 45, 619-613.